Literature DB >> 16181920

Restitution of the aortic valve: what is new, what is proven, and what is obsolete?

Johannes M Albes1, Ulrich A Stock, Martin Hartrumpf.   

Abstract

Restitution strategies of the insufficient aortic valve belong to the clinical armamentarium. To date, the accumulated body of evidence comprises 126 articles dealing with restitution strategies on the insufficient aortic valve with concomitant aortic surgery. In a cumulative analysis an almost identical number of reimplantation (506) and remodeling (489) procedures were found in the literature, whereas 357 patients underwent aortic valve resuspension. The cumulative results tend to favor the reimplantation technique in terms of longevity of the reconstruction, particularly in congenital degenerative disorders of the aortic wall, whereas remodeling appears to exhibit a more physiologic behavior of the reconstructed valve and re-suspension serves as a simplified approach particularly in acute type A dissection. Although restitution of the native aortic valve has its place in current treatment options, the accumulated worldwide numbers indicate that it is not yet routinely implemented in the vast majority of cardiac institutions.

Entities:  

Mesh:

Year:  2005        PMID: 16181920     DOI: 10.1016/j.athoracsur.2005.02.010

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  3 in total

Review 1.  Aortic valve repair update.

Authors:  Tatsuhiko Komiya
Journal:  Gen Thorac Cardiovasc Surg       Date:  2015-02-05

2.  Automatic evaluation of the Valsalva sinuses from cine-MRI.

Authors:  Cédric Blanchard; Alain Lalande; Tadeusz Sliwa; Olivier Bouchot; Yvon Voisin
Journal:  MAGMA       Date:  2011-09-18       Impact factor: 2.310

3.  Does aortic valve repair in valve-sparing aortic root reconstruction compromise the longevity of the procedure?

Authors:  Ricardo Ribeiro Dias; José Augusto Duncan; Fabrício José de Souza Dinato; Lucas Lacerda Araújo; Hugo Monteiro Neder Issa; Fábio Fernandes; Charles Mady; Fábio Biscegli Jatene
Journal:  Clinics (Sao Paulo)       Date:  2017-04       Impact factor: 2.365

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.